IPO Proceeds and Their Importance
| Issue Object | Estimated Amount |
|---|---|
| Repayment or prepayment of borrowings | Rs.17 crore |
| Working-capital requirements | Rs.4.30 crore |
| Unidentified acquisitions and general corporate purposes | Balance proceeds |
Debt repayment is the most important objective because ABH Healthcare reported borrowings of Rs.35.83 crore in FY24, compared with net worth of only Rs.6.30 crore. Utilising Rs.17 crore for repayment could reduce interest costs and strengthen the balance sheet.
However, the proposed acquisitions have not been identified, creating uncertainty regarding execution, valuation and integration.
Key Performance Indicators
| KPI | FY24 |
|---|---|
| ROE/RoNW | 30.33% |
| ROCE | 14.96% |
| Debt-to-Equity | 5.69 |
| PAT Margin | 4.00% |
| EBITDA Margin | 16.66% |
| NAV Per Share | Rs.7.87 |
The reported ROE appears attractive, but it is magnified by the company’s low equity base and high borrowings. Debt-to-equity of 5.69 times represents the biggest financial risk. ROCE of 14.96% is moderate, while a 4% PAT margin provides limited protection against rising employee, equipment and finance costs.
IPO Valuation
At the upper price of Rs.102, ABH Healthcare will have a post-issue market capitalisation of approximately Rs.116.58 crore.
A reliable price-to-earnings comparison cannot be made from the supplied information because recent earnings are weak and the December 2024 figures appear internally inconsistent. Investors should verify the final RHP and calculate valuation using normalised annual earnings before applying.
Lot Size and Investment Risk
| Investor Category | Lots | Shares | Amount |
|---|---|---|---|
| Individual Investor | 2 | 2,400 | Rs.2,44,800 |
| S-HNI Minimum | 3 | 3,600 | Rs.3,67,200 |
| B-HNI Minimum | 9 | 10,800 | Rs.11,01,600 |
The high minimum retail commitment significantly increases concentration risk for individual investors.
Reservation Structure
- QIB: Not more than 50% of the net issue
- Retail: Not less than 35%
- NII: Not less than 15%
- Market maker: 1,72,800 shares
Issue Management
Lead Manager: Fedex Securities Pvt. Ltd.
Registrar: Bigshare Services Pvt. Ltd.
Company Address: Anil Baghi Road, Firozepur, Punjab – 152002
Final Chanakya Verdict
ABH Healthcare has an established hospital, multiple specialities and insurer empanelments. The fresh issue and proposed debt reduction are positive. Nevertheless, falling profits, heavy borrowings, single-location concentration and inconsistent financial disclosures substantially increase risk.
Rating: ⭐⭐½☆☆ (2.5/5)
Recommendation: High-Risk Selective Apply. Consider only if the financial discrepancies are clarified and QIB subscription, GMP and overall demand remain strong. Conservative investors should avoid the issue.